Stock listing

gettex:1YR Immunovia AB Aktie

German listing (gettex) of Immunovia AB · home listing Stockholm:IMMNOV

Follow Immunovia AB into a list and get an email when it puts out news.

Home listing price · OMXSTO:IMMNOV

0.089 SEK -0.003 (-3.6%)

Close on Oct 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OMXSTO:IMMNOV

Since Jul 6, 2026 -53.6% · daily closes, Jul 6, 2026 – Oct 16, 2026, adjusted for splits
Day range
0.080 – 0.092 SEKOct 16, 2026
Volume
5.17M sharesOct 16, 2026
Market value
59.60M SEKAt the close on Oct 16, 2026 · price × 672.7M shares outstanding
Immunovia AB logo
Ticker
gettex:1YR
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
gettex
Currency
EUR

What changed lately

Calls

Replays

  • Immunovia (Stockholm:IMMNOV) Q2 2026 Earnings Call

    Thu, Aug 06, 2026 · 9:00 AM ET

    Watch Transcript

  • Immunovia (Stockholm:IMMNOV) Q1 2026 Earnings Call

    Thu, May 07, 2026 · 9:00 AM ET

    Watch Transcript

  • Immunovia (Stockholm:IMMNOV) Q4 2025 Earnings Call

    Tue, Feb 24, 2026 · 9:00 AM ET

    Watch Transcript

Latest news

Immunovia Publishes Interim Report for April-June 2026

Aug 6, 2026

Immunovia announces new performance data for PancreaSure ahead of upcoming application for Medicare coverage

Jun 15, 2026

Immunovia publishes final AFFIRM study results in Journal of Clinical Oncology confirming strong diagnostic performance of PancreaSure

Jun 10, 2026

Immunovia Publishes Interim Report for January-March 2026

May 7, 2026

Immunovia launches ASSURE registry to evaluate real-world clinical impact of PancreaSure in high-risk pancreatic cancer surveillance

May 5, 2026

Proposal for resolution on (A) option program for board members; and (B) directed issue of warrants and approval of transfer of warrants (Proposal for resolution on A option program for board members and B directed issue of warrants and approval of transfer of warrants 45758458 v6)

May 4, 2026

Proposal for resolution on (A) option program for management and key persons; and (B) directed issue of warrants and approval of transfer of warrants (Proposal for resolution on A option program for management and key persons and B directed issue of warrants and approval of transfer of warrants)

Apr 14, 2026

Proposal for resolution on authorization of the board to resolve on new issue of shares (Proposal for resolution on authorization regarding issues)

Apr 14, 2026

Annual Report (Immunovia AB publ Annual Report 2025)

Apr 14, 2026

Statement from nomination committee (Statement from nomination committee 2026)

Apr 14, 2026

All Immunovia AB news

Decks

Immunovia AB on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
17 in the last 12 months · 17 in all · newest Aug 6, 2026 · oldest 2026
Calls
9 calls with a replay · 9 with a transcript · latest Aug 6, 2026
Decks
11 decks · latest May 7, 2026

Where Immunovia AB is listed

ListingExchangeCountryCurrency
Stockholm:IMMNOV · Home listingStockholmSwedenSEK
gettex:1YR · This pagegettexGermanyEUR
LSE:0G8XLSEUnited KingdomSEK
Aquis:IMMNOSAquisUnited KingdomSEK
Aquis:IMMNOSAquisUnited KingdomSEK
Frankfurt:1YRFrankfurtGermanyEUR
Munich:1YRMunichGermanyEUR
OTC:IMMVFOTCUnited StatesUSD

Log in to ask 6ix AI your own questions about Immunovia AB.